121 related articles for article (PubMed ID: 10225578)
1. Ten years of ciprofloxacin: the past, present and future. Acute exacerbations of chronic bronchitis. Introduction.
Wilson R
J Antimicrob Chemother; 1999 Mar; 43 Suppl A():95-6. PubMed ID: 10225578
[No Abstract] [Full Text] [Related]
2. Guidelines for the treatment of acute exacerbations of chronic bronchitis.
Grossman RF
Chest; 1997 Dec; 112(6 Suppl):310S-313S. PubMed ID: 9400894
[No Abstract] [Full Text] [Related]
3. [The role of ciprofloxacin in the treatment of chronic bronchitis].
Zuck P
Presse Med; 1998 Mar; 27(12):594-6. PubMed ID: 9767959
[No Abstract] [Full Text] [Related]
4. Introduction: COPD--the role of infection.
Niederman MS
Chest; 1997 Dec; 112(6 Suppl):301S-302S. PubMed ID: 9400892
[No Abstract] [Full Text] [Related]
5. Treating acute exacerbations of chronic bronchitis in the face of antibiotic resistance.
Adams SG; Anzueto A
Cleve Clin J Med; 2000 Sep; 67(9):625-8, 631-3. PubMed ID: 10992620
[TBL] [Abstract][Full Text] [Related]
6. Introduction: the role of bacterial infection in chronic bronchitis.
Wilson R; Grossman R
Semin Respir Infect; 2000 Mar; 15(1):1-6. PubMed ID: 10749544
[TBL] [Abstract][Full Text] [Related]
7. The use of moxifloxacin for acute exacerbations of chronic obstructive pulmonary disease and chronic bronchitis.
Wilson R; Macklin-Doherty A
Expert Rev Respir Med; 2012 Nov; 6(5):481-92. PubMed ID: 23113693
[TBL] [Abstract][Full Text] [Related]
8. Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD.
Stockley RA; O'Brien C; Pye A; Hill SL
Chest; 2000 Jun; 117(6):1638-45. PubMed ID: 10858396
[TBL] [Abstract][Full Text] [Related]
9. Acute exacerbations of chronic bronchitis.
Grossman RF
Hosp Pract (1995); 1997 Oct; 32(10):85-9, 92-4. PubMed ID: 9341637
[TBL] [Abstract][Full Text] [Related]
10. [Third-generation cephalosporins in the treatment of exacerbations in chronic obstructive lung diseases].
Carrion Valero F
An Med Interna; 1995 Dec; 12(12):623. PubMed ID: 8679815
[No Abstract] [Full Text] [Related]
11. Double-blind comparative study of ofloxacin (Hoe 280) and trimethoprim-sulfamethoxazole in the treatment of patients with acute exacerbations of chronic bronchitis and chronic obstructive lung disease.
Boye NP; Gaustad P
Infection; 1991; 19 Suppl 7():S388-90. PubMed ID: 1804789
[TBL] [Abstract][Full Text] [Related]
12. Cefuroxime axetil vs. augmentin for the treatment of acute bronchitis and exacerbation of chronic obstructive pulmonary disease.
Landau Z; Schlaffer F; Pitlik S
Isr J Med Sci; 1992 Nov; 28(11):797-9. PubMed ID: 1468894
[No Abstract] [Full Text] [Related]
13. Acute exacerbations of chronic bronchitis. Preventing treatment failures and early reinfection.
Verghese A; Ismail HM
Postgrad Med; 1994 Dec; 96(8):75-6, 79-82, 87-9. PubMed ID: 7991479
[TBL] [Abstract][Full Text] [Related]
14. Pro: antibiotics for chronic bronchitis with exacerbations.
Isada CM
Semin Respir Infect; 1993 Dec; 8(4):243-53. PubMed ID: 7938921
[TBL] [Abstract][Full Text] [Related]
15. Sputum antimicrobial levels and clinical outcome in bronchitis.
Hitt JA; Gerding DN
Semin Respir Infect; 1991 Jun; 6(2):122-8. PubMed ID: 1771303
[TBL] [Abstract][Full Text] [Related]
16. [Infections of the airways--when are antibiotics indicated?].
Lode H
Pneumologie; 1990 May; 44(5):763-6. PubMed ID: 2193309
[No Abstract] [Full Text] [Related]
17. [Chronic bronchitis: when are antibiotics indicated?].
Gerber AU
Ther Umsch; 1992 Oct; 49(10):692-6. PubMed ID: 1440437
[TBL] [Abstract][Full Text] [Related]
18. Defining subsets of patients with chronic bronchitis.
Wilson R; Wilson CB
Chest; 1997 Dec; 112(6 Suppl):303S-309S. PubMed ID: 9400893
[No Abstract] [Full Text] [Related]
19. Clarithromycin versus cefaclor in lower respiratory tract infections. The Canadian Bronchitis Study Group.
Fong IW; Laforge J; Dubois J; Small D; Grossman R; Zakhari R
Clin Invest Med; 1995 Apr; 18(2):131-8. PubMed ID: 7788958
[TBL] [Abstract][Full Text] [Related]
20. Treatment of acute bacterial exacerbations of chronic obstructive pulmonary disease in hospitalised patients--a comparison of meropenem and imipenem/cilastatin. COPD Study Group.
Hamacher J; Vogel F; Lichey J; Kohl FV; Diwok K; Wendel H; Lode H
J Antimicrob Chemother; 1995 Jul; 36 Suppl A():121-33. PubMed ID: 8543488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
